feed,title,long_url,short_url
Benzinga,Jasper Therapeutics Reveals Treatment of First Patient in the Phase 1/2 Study of JPS191 for Fanconi Anemia,https://benzinga.com/general/biotech/22/05/27257281/jasper-therapeutics-reveals-treatment-of-first-patient-in-the-phase-12-study-of-jps191-for-fancon,https://bit.ly/3NgGaww
Benzinga,Gilead Sciences' Can Resume Injectable Lenacapavir Trial(s) For HIV Infection,https://benzinga.com/general/biotech/22/05/27244717/gilead-sciences-can-resume-injectable-lenacapavir-trial-s-for-hiv-infection,https://bit.ly/3sCbU7m
